Ledger.Open graph →
SEC Form D · filed June 22, 2021

Nautilus Biotechnology, Inc

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Other
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Farzad Nazem · Menlo Park, CADirectorSujal Patel · Menlo Park, CAExec · DirectorMichael Altman · ATLANTA, GADirectorMatthew Posard · La Jolla, CADirectorMatthew S. Mcilwain · SEATTLE, WADirectorParag Mallick · Menlo Park, CAExec · DirectorMelissa Epperly · Seattle, WADirectorNicholas S. Nelson · Seattle, WAExecSubra S. Sankar · Seattle, WAExecMatthew S. Murphy · Seattle, WAExecMichael Altman · ATLANTA, GADirectorVijay Pande · Santa Barbara, CADirectorAnna Mowry · Seattle, WAExecMelissa Epperly · Seattle, WADirectorNicholas S. Nelson · Seattle, WAExecSubra S. Sankar · Seattle, WAExecFarzad Nazem · Menlo Park, CADirectorMatthew S. Murphy · Seattle, WAExecSujal Patel · Seattle, WAExec · DirectorMichael Altman · Dobbs Ferry, NYDirectorVijay Pande · Santa Barbara, CADirectorMatthew Posard · La Jolla, CADirectorAnna Mowry · Seattle, WAExecMatthew S. Mcilwain · SEATTLE, WADirectorParag Mallick · Menlo Park, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗